vs

Side-by-side financial comparison of AbbVie (ABBV) and ARROW ELECTRONICS, INC. (ARW). Click either name above to swap in a different company.

AbbVie is the larger business by last-quarter revenue ($16.6B vs $8.7B, roughly 1.9× ARROW ELECTRONICS, INC.). AbbVie runs the higher net margin — 10.9% vs 2.2%, a 8.7% gap on every dollar of revenue. On growth, ARROW ELECTRONICS, INC. posted the faster year-over-year revenue change (20.1% vs 10.0%). AbbVie produced more free cash flow last quarter ($4.9B vs $172.6M). Over the past eight quarters, AbbVie's revenue compounded faster (16.2% CAGR vs 12.4%).

AbbVie Inc. is an American pharmaceutical company headquartered in North Chicago, Illinois. They have produced drugs to treat a wide range of medical issues.

Arrow Electronics, Inc., is an American company headquartered in Centennial, Colorado. A global provider of electronic components and enterprise computing products, the company specializes in distribution and value-added services for original equipment manufacturers, value-added resellers, managed service providers, contract manufacturers and other commercial customers. The company is ranked No. 154 in the Fortune 500 list of the largest United States corporations by total revenue. The compan...

ABBV vs ARW — Head-to-Head

Bigger by revenue
ABBV
ABBV
1.9× larger
ABBV
$16.6B
$8.7B
ARW
Growing faster (revenue YoY)
ARW
ARW
+10.1% gap
ARW
20.1%
10.0%
ABBV
Higher net margin
ABBV
ABBV
8.7% more per $
ABBV
10.9%
2.2%
ARW
More free cash flow
ABBV
ABBV
$4.7B more FCF
ABBV
$4.9B
$172.6M
ARW
Faster 2-yr revenue CAGR
ABBV
ABBV
Annualised
ABBV
16.2%
12.4%
ARW

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ABBV
ABBV
ARW
ARW
Revenue
$16.6B
$8.7B
Net Profit
$1.8B
$194.6M
Gross Margin
72.6%
11.5%
Operating Margin
27.3%
3.4%
Net Margin
10.9%
2.2%
Revenue YoY
10.0%
20.1%
Net Profit YoY
8354.5%
96.2%
EPS (diluted)
$1.02
$3.74

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ABBV
ABBV
ARW
ARW
Q4 25
$16.6B
$8.7B
Q3 25
$15.8B
$7.7B
Q2 25
$15.4B
$7.6B
Q1 25
$13.3B
$6.8B
Q4 24
$15.1B
$7.3B
Q3 24
$14.5B
$6.8B
Q2 24
$14.5B
$6.9B
Q1 24
$12.3B
$6.9B
Net Profit
ABBV
ABBV
ARW
ARW
Q4 25
$1.8B
$194.6M
Q3 25
$186.0M
$109.2M
Q2 25
$938.0M
$187.7M
Q1 25
$1.3B
$79.7M
Q4 24
$-22.0M
$99.2M
Q3 24
$1.6B
$100.6M
Q2 24
$1.4B
$108.7M
Q1 24
$1.4B
$83.6M
Gross Margin
ABBV
ABBV
ARW
ARW
Q4 25
72.6%
11.5%
Q3 25
66.4%
10.8%
Q2 25
71.8%
11.2%
Q1 25
70.0%
11.4%
Q4 24
70.9%
11.0%
Q3 24
70.9%
11.5%
Q2 24
70.9%
12.3%
Q1 24
66.7%
12.4%
Operating Margin
ABBV
ABBV
ARW
ARW
Q4 25
27.3%
3.4%
Q3 25
12.1%
2.3%
Q2 25
31.7%
2.5%
Q1 25
28.0%
2.3%
Q4 24
-9.9%
2.7%
Q3 24
26.5%
2.6%
Q2 24
27.6%
3.1%
Q1 24
22.7%
2.7%
Net Margin
ABBV
ABBV
ARW
ARW
Q4 25
10.9%
2.2%
Q3 25
1.2%
1.4%
Q2 25
6.1%
2.5%
Q1 25
9.6%
1.2%
Q4 24
-0.1%
1.4%
Q3 24
10.8%
1.5%
Q2 24
9.5%
1.6%
Q1 24
11.1%
1.2%
EPS (diluted)
ABBV
ABBV
ARW
ARW
Q4 25
$1.02
$3.74
Q3 25
$0.10
$2.09
Q2 25
$0.52
$3.59
Q1 25
$0.72
$1.51
Q4 24
$-0.03
$1.87
Q3 24
$0.88
$1.88
Q2 24
$0.77
$2.01
Q1 24
$0.77
$1.53

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ABBV
ABBV
ARW
ARW
Cash + ST InvestmentsLiquidity on hand
$5.3B
$306.5M
Total DebtLower is stronger
$58.9B
Stockholders' EquityBook value
$-3.3B
$6.6B
Total Assets
$134.0B
$29.1B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ABBV
ABBV
ARW
ARW
Q4 25
$5.3B
$306.5M
Q3 25
$5.7B
$213.6M
Q2 25
$6.5B
$222.0M
Q1 25
$5.2B
$231.9M
Q4 24
$5.6B
$188.8M
Q3 24
$7.3B
$248.0M
Q2 24
$13.2B
$213.0M
Q1 24
$18.1B
$242.8M
Total Debt
ABBV
ABBV
ARW
ARW
Q4 25
$58.9B
Q3 25
$63.0B
Q2 25
$63.0B
Q1 25
$64.5B
Q4 24
$60.3B
Q3 24
$58.5B
Q2 24
$58.0B
Q1 24
$63.8B
Stockholders' Equity
ABBV
ABBV
ARW
ARW
Q4 25
$-3.3B
$6.6B
Q3 25
$-2.6B
$6.4B
Q2 25
$-183.0M
$6.3B
Q1 25
$1.4B
$5.9B
Q4 24
$3.3B
$5.8B
Q3 24
$6.0B
$6.0B
Q2 24
$6.8B
$5.7B
Q1 24
$8.0B
$5.7B
Total Assets
ABBV
ABBV
ARW
ARW
Q4 25
$134.0B
$29.1B
Q3 25
$133.9B
$24.5B
Q2 25
$137.2B
$24.3B
Q1 25
$136.2B
$21.4B
Q4 24
$135.2B
$21.8B
Q3 24
$143.4B
$20.9B
Q2 24
$141.9B
$20.1B
Q1 24
$148.9B
$20.3B
Debt / Equity
ABBV
ABBV
ARW
ARW
Q4 25
Q3 25
Q2 25
Q1 25
45.44×
Q4 24
18.15×
Q3 24
9.70×
Q2 24
8.56×
Q1 24
7.97×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ABBV
ABBV
ARW
ARW
Operating Cash FlowLast quarter
$5.2B
$199.9M
Free Cash FlowOCF − Capex
$4.9B
$172.6M
FCF MarginFCF / Revenue
29.4%
2.0%
Capex IntensityCapex / Revenue
2.0%
0.3%
Cash ConversionOCF / Net Profit
2.87×
1.03×
TTM Free Cash FlowTrailing 4 quarters
$17.8B
$-37.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ABBV
ABBV
ARW
ARW
Q4 25
$5.2B
$199.9M
Q3 25
$7.0B
$-281.7M
Q2 25
$5.2B
$-205.9M
Q1 25
$1.6B
$351.7M
Q4 24
$7.0B
$326.5M
Q3 24
$5.4B
$80.6M
Q2 24
$2.3B
$320.2M
Q1 24
$4.0B
$403.2M
Free Cash Flow
ABBV
ABBV
ARW
ARW
Q4 25
$4.9B
$172.6M
Q3 25
$6.6B
$-312.0M
Q2 25
$4.9B
$-224.5M
Q1 25
$1.4B
$326.7M
Q4 24
$6.8B
$303.9M
Q3 24
$5.2B
$62.0M
Q2 24
$2.0B
$298.1M
Q1 24
$3.8B
$373.7M
FCF Margin
ABBV
ABBV
ARW
ARW
Q4 25
29.4%
2.0%
Q3 25
42.1%
-4.0%
Q2 25
31.7%
-3.0%
Q1 25
10.5%
4.8%
Q4 24
44.7%
4.2%
Q3 24
35.9%
0.9%
Q2 24
14.0%
4.3%
Q1 24
31.3%
5.4%
Capex Intensity
ABBV
ABBV
ARW
ARW
Q4 25
2.0%
0.3%
Q3 25
2.4%
0.4%
Q2 25
1.7%
0.2%
Q1 25
1.8%
0.4%
Q4 24
1.9%
0.3%
Q3 24
1.7%
0.3%
Q2 24
1.7%
0.3%
Q1 24
1.6%
0.4%
Cash Conversion
ABBV
ABBV
ARW
ARW
Q4 25
2.87×
1.03×
Q3 25
37.76×
-2.58×
Q2 25
5.49×
-1.10×
Q1 25
1.27×
4.41×
Q4 24
3.29×
Q3 24
3.49×
0.80×
Q2 24
1.66×
2.95×
Q1 24
2.95×
4.82×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons